About LightDeck Diagnostics
LightDeck Diagnostics is a company based in Boulder (United States) founded in 2009 by Mike Lochhead was acquired by Heska in September 2022. LightDeck Diagnostics has raised $57.02 million across 16 funding rounds from investors including HHS, Heska and DARPA. LightDeck Diagnostics offers products and services including COVID-19 Antigen Test, COVID-19 Antibody Test, Hormones Test, Host Response Test, and Cardiac Markers Test. LightDeck Diagnostics operates in a competitive market with competitors including EKF, ProciseDx, LumiraDx, SpinChip and EDX Medical Group, among others.
- Headquarter Boulder, United States
- Founders Mike Lochhead
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LightDeck Diagnostics
LightDeck Diagnostics offers a comprehensive portfolio of products and services, including COVID-19 Antigen Test, COVID-19 Antibody Test, Hormones Test, Host Response Test, and Cardiac Markers Test.
Detects current COVID-19 infections quickly for timely intervention
Identifies antibodies indicating prior COVID-19 exposure
Assesses thyroid and reproductive health markers in patients
Detects biomarkers in blood for overall immune response evaluation
Quickly evaluates chest pain for potential cardiac issues
Checks for common toxins to ensure water safety standards
People of LightDeck Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of LightDeck Diagnostics
LightDeck Diagnostics has successfully raised a total of $57.02M across 16 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in LightDeck Diagnostics
LightDeck Diagnostics has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Heska and DARPA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Entrepreneur mentorship and selective investments are provided by Incubic.
|
Locked | Locked | Locked | |
|
Venture capital is offered by Boulder Ventures for innovative companies.
|
Locked | Locked | Locked | |
|
Late-seed stage startups are invested in by Entrada Ventures.
|
Locked | Locked | Locked |
Investor details for LightDeck Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LightDeck Diagnostics
Investment portfolio details for LightDeck Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - LightDeck Diagnostics
Detailed financials for LightDeck Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lightdeck Diagnostics Comparisons
Peer comparison for LightDeck Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LightDeck Diagnostics
LightDeck Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EKF, ProciseDx, LumiraDx, SpinChip and EDX Medical Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Point-of-care and laboratory blood analyzers are developed by EKF.
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic devices for immunoassay tests are provided to clinicians.
|
|
| Locked | Locked | Locked |
Cloud based diagnostics platform for point of care diagnosing
|
|
| Locked | Locked | Locked |
In-vitro diagnostic test cartridges are developed and manufactured via R&D.
|
|
| Locked | Locked | Locked |
Medical diagnostics solutions are researched by the laboratory.
|
Detailed competitors of LightDeck Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lightdeck Diagnostics
Complete news archive for LightDeck Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LightDeck Diagnostics
LightDeck Diagnostics was founded in 2009.
LightDeck Diagnostics is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
Nick Traggis is the current CEO of LightDeck Diagnostics.
LightDeck Diagnostics is a funded company, having raised a total of $57.02M across 16 funding rounds to date.
LightDeck Diagnostics was founded in 2009 in Boulder, United States, within the medical diagnostics sector. Point-of-care devices for multiplex assays are developed using the proprietary LightDeck platform, which integrates an advanced laser waveguide with novel materials and manufacturing techniques. In vitro diagnostic panels are provided through this system. The flagship MBio Array System employs disposable cartridges for automated and simultaneous fluorescence immunoassays.
LightDeck Diagnostics offers COVID-19 Antigen Test, COVID-19 Antibody Test, Hormones Test, Host Response Test, and 2 more products and services.